Catalog Number 186760445 |
Device Problem
Break (1069)
|
Patient Problems
Pain (1994); Loss of Range of Motion (2032); Ambulation Difficulties (2544); Paresthesia (4421)
|
Event Type
Injury
|
Event Description
|
Device report from synthes reports an event in brazil as follows: it was reported that a procedure of lumbar arthrodesis was performed on a patient.After 10 months of the procedure, the patient came into contact with the doctor complaining of strong lumbar pain, with irradiation to the left lower limb and paresthesia associated with important functional limitation, with difficulty performing daily work activities.Clinical and radiological tests were performed and proved the screw breakage.A new procedure was carried out for removing the screw and implanting a new one.This report involves one (1) viper prime cfx fen x-tab polyaxial screw 5.5 6 x 45mm.This is report 1 of 1 for (b)(4).
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: d9: complainant part is not expected to be returned for manufacturer review/investigation.H3, h6: the investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.A review of the receiving inspection (ri) for viper prime cfxfen xtab 6x45mm, was conducted identifying that lot number tbaish was released in three batches.¿ batch1: lot qty of (b)(4) units were released on 28 sept 2021 with no discrepancies.¿ batch2: lot qty of (b)(4) units were released on 01 nov 2021 with no discrepancies.¿ batch3: lot qty of (b)(4) units were released on 07 mar 2022 with no discrepancies.Supplier: depuy: tomz corp.As a result, the ri identified no issues during the manufacturing and release of this device that could have contributed to the problem reported by the customer.The product was not returned to depuy synthes, however photos were provided for review.The photo investigation revealed that one of the two screws shown on image is broken from the threaded upper middle part.Broken fragment is not observed.With the available information, it is not possible to establish a potential cause for the failure of the device.Since the device was not returned, a dimensional inspection cannot be performed.The overall complaint was confirmed as the observed condition of the viper prime cfxfen xtab 6x45mm would contribute to the complained device issue.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.There is no indication that a design or manufacturing issue has caused the complaint condition.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.If information is obtained that was not available for this medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|
|